Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation

Journal of Clinical Oncology

Volumn 31, Issue 31, 2013, Pages 3914-3919

  Valentini, Adriana ^a   Finch, Amy ^a   Lubinśki, Jan ^h   Byrski, Tomasz ^h   Ghadirian, Parviz ^d   Kim Sing, Charmaine ^e   Lynch, Henry T ^f   Ainsworth, Peter J ^c   Neuhausen, Susan L ^g   Greenblatt, Ellen ^b   Singer, Christian ⁱ   Sun, Ping ^a   Narod, Steven A ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h POMERANIAN MEDICAL UNIVERSITY   (Poland)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CHEMOTHERAPY INDUCED AMENORRHEA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; GENE MUTATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR INVASION; TUMOR SUPPRESSOR GENE; AGE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; GENETICS; INFORMATION PROCESSING; MUTATION; BREAST NEOPLASMS; CHEMICALLY INDUCED; CLINICAL TRIAL;

ADULT; AGE FACTORS; AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DATA COLLECTION; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MUTATION; TAMOXIFEN;

EID: 84891637816     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.7893     Document Type: Article

References (35)

1. Partridge AH, Gelber S, Peppercorn J, et al: Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174-4222, 2004
2. Daniel JM: Estrogens, estrogen receptors, and female cognitive aging: The impact of timing. Horm Behav 63:231-237, 2013
3. Oktay K, Kim JY, Barad D, et al: Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 28:240-244, 2010
4. Speroff L, Fritz MA: Clinical Gynecologic Endocrinology and Infertility (ed 7). Philadelphia, PA, Lippincott Williams and Wilkins, 2005
5. Strauss JF III, Robert L: Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management (ed 6). Philadelphia, PA, Elsevier Saunders, 2009
6. Fleischer RT, Vollenhoven BJ, Weston GC: The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 66:248-254, 2011
7. Clemons M, Simmons C: Identifying menopause in breast cancer patients: Considerations and implications. Breast Cancer Res Treat 104:115-120, 2007 (Pubitemid 47084222)
8. Bines J, Oleske DM, Cobleigh MA, et al: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996 (Pubitemid 26134232)
9. Meirow D, Biederman H, Anderson RA, et al: Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 53:727-739, 2010
10. Metcalf MG, Donald RA, Livesey JH: Pituitaryovarian function in normal women during the menopausal transition. Clin Endocrinol (Oxf) 14:245-255, 1981 (Pubitemid 11053525)
11. Blumenfeld Z: Chemotherapy and fertility. Best Pract Res Clin Obstet Gynaecol 26:379-390, 2012
12. Kim CH, Jeon GH: Fertility preservation in female cancer patients. ISRN Obstet Gynecol [epub ahead of print on January 26, 2012]
13. Pérez-Fidalgo JA, Roselló S, García-Garré E, et al: Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: The impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat 120:245-251, 2010
14. Morgan S, Anderson RA, Gourley C, et al: How do chemotherapeutic agents damage the ovary? Hum Reprod Update 18:525-535, 2012
15. Anderson RA, Cameron DA: Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 96:1336-1343, 2011
16. Walshe JM, Denduluri N, Swain SM: Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769-5779, 2006 (Pubitemid 46646480)
17. Reference deleted
18. Petrek JA, Naughton MJ, Case LD, et al: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 24:1045-1051, 2006 (Pubitemid 46638800)
19. Lee S, Kil WJ, Chun M: Chemotherapy-related amenorrhea in premenopausal women with breast cancer. Menopause 16:98-103, 2009
20. Torino F, Barnabei A, De Vecchis L: Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. Endocr Relat Cancer 19:R21-R33, 2012
21. Rzepka-Górska I, Tarnowski B, Chudecka-Głaz A, et al: Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Res Treat 100:59-63, 2006
22. Partridge A, Gelber S, Gelber RD, et al: Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer 43:1646-1653, 2007 (Pubitemid 47042368)
23. Swain SM, Land SR, Ritter MW, et al: Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 113:315-320, 2009
24. Jung M, Shin HJ, Rha SY, et al: The clinical outcome of chemotherapy-induced-amenorrhea in premenopausal young patients with breast cancer with long-term follow-up. Ann Surg Oncol 17:3259-3268, 2010
25. Fornier MN, Modi S, Panageas KS, et al: Incidence of chemotherapy- induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104:1575-1579, 2005 (Pubitemid 41437419)
26. Smith IE, Dowsett M, Yap YS, et al: Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: Caution and suggested guidelines. J Clin Oncol 24:2444-2447, 2006 (Pubitemid 46630620)
27. Reference deleted
28. Reference deleted
29. Huser M, Crha I, Ventruba P, et al: Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod 23:863-868, 2008
30. Pagani O, Partridge A, Korde L, et al: Pregnancy after breast cancer: If you wish, ma'am. Breast Cancer Res Treat 129:309-317, 2011
31. Wellons M, Ouyang P, Schreiner PJ, et al: Early menopause predicts future coronary heart disease and stroke: The multi-ethnic study of atherosclerosis. Menopause 19:1081-1087, 2012
32. Shuster LT, Rhodes DJ, Gostout BS, et al: Premature menopause or early menopause: Longterm health consequences. Maturitas 65:161-166, 2010
33. Cooper GS, Sandler DP: Age at natural menopause and mortality. Ann Epidemiol 8:229-235, 1998 (Pubitemid 28208940)
34. Finch A, Narod SA: Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review. Maturitas 70:261-265, 2011
35. Huzarski T, Byrski T, Gronwald J, et al: Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J Clin Oncol 31:3191-3196, 2013